CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment

Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial

(2014) Robert Coleman et al.   LANCET ONCOLOGY

Omic-profiling in breast cancer metastasis to bone: Implications for mechanisms, biomarkers and treatment

(2013) Steven L. Wood et al.   CANCER TREATMENT REVIEWS

Laser Microdissection and Two-Dimensional Difference Gel Electrophoresis Reveal the Role of a Novel Macrophage-Capping Protein in Lymph Node Metastasis in Gastric Cancer

(2013) Hiroshi Ichikawa et al.   JOURNAL OF PROTEOME RESEARCH

Identification ofNOGas a Specific Breast Cancer Bone Metastasis-supporting Gene

(2012) Maria Tarragona et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts

(2012) Samantha A Simpkins et al.   JOURNAL OF PATHOLOGY

Differential proteomic analysis of a human breast tumor and its matched bone metastasis identifies cell membrane and extracellular proteins associated with bone metastasis

(2012) Bruno Dumont et al.   JOURNAL OF PROTEOME RESEARCH

Proteomic identification of the macrophage-capping protein as a protein contributing to the malignant features of hepatocellular carcinoma

(2012) Kazuya Kimura et al.   Journal of Proteomics

Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial

(2012) Alexander HG Paterson et al.   LANCET ONCOLOGY

The Significance of a Group of Molecular Markers and Clinicopathological Factors in Identifying Colorectal Liver Metastasis

(2011) Jian-Hui Wu et al.   HEPATO-GASTROENTEROLOGY

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial

(2011) Michael Gnant et al.   LANCET ONCOLOGY

Breast-Cancer Adjuvant Therapy with Zoledronic Acid

(2011) Robert E. Coleman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Overexpression of Gelsolin-Like Actin-Capping Protein Is Associated with Progression of Lung Adenocarcinoma

(2011) Fangchun Shao et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis

(2010) Si-Guang Xu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Proteomic Molecular Portrait of Interface Zone in Breast Cancer

(2010) Suki Kang et al.   JOURNAL OF PROTEOME RESEARCH

RGS-GAIP-Interacting Protein Controls Breast Cancer Progression

(2010) L. Wang et al.   MOLECULAR CANCER RESEARCH

Therapeutic Implications of GIPC1 Silencing in Cancer

(2010) Thomas W. Chittenden et al.   PLoS One

The c.5242C>A BRCA1 missense variant induces exon skipping by increasing splicing repressors binding

(2009) Stefania Millevoi et al.   BREAST CANCER RESEARCH AND TREATMENT

Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals

(2009) Xiang H.-F. Zhang et al.   CANCER CELL

The type III TGF-β receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-β signaling

(2009) Jason D. Lee et al.   CARCINOGENESIS

Upregulation of Hic-5 in glomerulosclerosis and its regulation of mesangial cell apoptosis

(2009) Nick Hornigold et al.   KIDNEY INTERNATIONAL

Genes that mediate breast cancer metastasis to the brain

(2009) Paula D. Bos et al.   NATURE

Native human autoantibodies targeting GIPC1 identify differential expression in malignant tumors of the breast and ovary

(2008) Victoria Yavelsky et al.   BMC CANCER

Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity

(2008) Hitomi Nomura et al.   BMC CANCER